Search

everythinglearnresearchcommunity

for

Search:↓

Different forms of the Vitamin D receptor can impact metabolic and hormone issues in Polycystic Ovary Syndrome.

Stress increases neurosteroids that help prevent seizures.

Spironolactone can reduce hair growth in women with hirsutism.

Spironolactone effectively reduces symptoms of hyperandrogenism like hirsutism and acne.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

An ovarian tumor can cause high male hormones in postmenopausal women.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Women with PCOS have higher levels of DHEA, IL-6, and TNF-α.

Altered DHEA metabolism in hair follicles may be linked to hair loss in balding men.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.